The Environmental Protection Agency calls arsenic the most prevalent environmental toxin and carcinogen in the United States (://www.atsdr.cdc.gov/cercla/07list.html). Arsenic causes cardiovascular and peripheral vascular diseases, neurological disorders, diabetes mellitus and various forms of cancer such as skin and bladder cancer. Arsenic is biomethylated by the liver enzyme As (III) S-adenosylmethionine (SAM) methyltransferase (AS3MT) to mono- and dimethylated species. Because the trivalent products methylarsenite (MAs(III)) and dimethylarsenite (DMAs(III)) are more toxic than inorganic arsenite, they have been proposed to be associated with arsenic carcinogenesis and other diseases in humans. Individuals with AS3MT polymorphisms produce increased amounts of methylated species. How methylation contributes to disease depends on the mechanism of human AS3MT and differences between wild type and polymorphic enzymes. The uncertainty over the consequences of methylation makes it imperative to understand how this enzyme works. The overall goal of this study is elucidation of the structure and function of hAS3MT and its polymorphic forms.

Public Health Relevance

Arsenic is the most pervasive environmental toxin and carcinogen in the United States, causing cardiovascular and peripheral vascular diseases, neurological disorders, diabetes mellitus and various forms of cancer such as skin and bladder cancer. We have characterized the enzyme As(III) S-adenosylmethionine methyltransferase (AS3MT) from a model system. In this application we propose to elucidate the mechanism of the human AS3MT to understand its role in arsenic-related diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
5R01ES023779-04
Application #
9388343
Study Section
Xenobiotic and Nutrient Disposition and Action Study Section (XNDA)
Program Officer
Tyson, Frederick L
Project Start
2014-12-11
Project End
2019-11-30
Budget Start
2017-12-01
Budget End
2018-11-30
Support Year
4
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Florida International University
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
071298814
City
Miami
State
FL
Country
United States
Zip Code
33199
Li, Jiaojiao; Packianathan, Charles; Rossman, Toby G et al. (2017) Nonsynonymous Polymorphisms in the Human AS3MT Arsenic Methylation Gene: Implications for Arsenic Toxicity. Chem Res Toxicol 30:1481-1491
Hao, Xiuli; Li, Xuanji; Pal, Chandan et al. (2017) Bacterial resistance to arsenic protects against protist killing. Biometals 30:307-311
Chen, Song-Can; Sun, Guo-Xin; Rosen, Barry P et al. (2017) Recurrent horizontal transfer of arsenite methyltransferase genes facilitated adaptation of life to arsenic. Sci Rep 7:7741
Yang, Hung-Chi; Rosen, Barry P (2016) New mechanisms of bacterial arsenic resistance. Biomed J 39:5-13
Li, Jiaojiao; Pawitwar, Shashank S; Rosen, Barry P (2016) The organoarsenical biocycle and the primordial antibiotic methylarsenite. Metallomics 8:1047-1055
Kumar, Nallani Vijay; Yang, Jianbo; Pillai, Jitesh K et al. (2016) Arsenic Directly Binds to and Activates the Yeast AP-1-Like Transcription Factor Yap8. Mol Cell Biol 36:913-22
Li, Jiaojiao; Mandal, Goutam; Rosen, Barry P (2016) Expression of arsenic resistance genes in the obligate anaerobe Bacteroides vulgatus ATCC 8482, a gut microbiome bacterium. Anaerobe 39:117-23
Dong, Hui; Madegowda, Mahendra; Nefzi, Adel et al. (2015) Identification of Small Molecule Inhibitors of Human As(III) S-Adenosylmethionine Methyltransferase (AS3MT). Chem Res Toxicol 28:2419-25
Dong, Hui; Xu, Wenzhong; Pillai, Jitesh K et al. (2015) High-throughput screening-compatible assays of As(III) S-adenosylmethionine methyltransferase activity. Anal Biochem 480:67-73
Dheeman, Dharmendra S; Packianathana, Charles; Pillai, Jitesh K et al. (2014) Response to the letter to the editor regarding our article (Dheeman et al., 2014). Chem Res Toxicol 27:2012

Showing the most recent 10 out of 12 publications